Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant
Nicole Liberio(Children's Hospital of Wisconsin), Larisa Broglie(Morgan Stanley Children's Hospital), Erin Doherty(QB3), Heather J. Symons(Johns Hopkins University), Mariam Allbee-Johnson(Medical College of Wisconsin), Muna Qayed(Emory University), Christopher C. Dvorak(University of California, San Francisco), Sandhya Kharbanda(UCSF Benioff Children's Hospital), Amy Moskop(Medical College of Wisconsin), Rachel Phelan(Children's Hospital of Wisconsin), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Christine L. Phillips(Cincinnati Children's Hospital Medical Center), Kristin Page, Neena Kapoor(Children's Hospital of Los Angeles), Javier Bolaños-Meade(Johns Hopkins University), Kirk R. Schultz(University of British Columbia), Akshay Sharma(St. Jude Children's Research Hospital), Amanda E. Lipsitt(Methodist Children’s Hospital), Kwang Woo Ahn(Medical College of Wisconsin), Bronwen E. Shaw(Medical College of Wisconsin), Rishikesh Chavan(Children's Hospital of Orange County)
Cited by 2
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577